Provided by Tiger Trade Technology Pte. Ltd.

Generation Bio Co.

5.34
-0.4000-6.97%
Post-market: 5.420.0798+1.49%19:17 EST
Volume:551.92K
Turnover:2.99M
Market Cap:35.98M
PE:-0.57
High:5.71
Open:5.70
Low:5.34
Close:5.74
52wk High:8.40
52wk Low:3.00
Shares:6.74M
Float Shares:4.95M
Volume Ratio:4.52
T/O Rate:11.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.3407
EPS(LYR):-19.7628
ROE:-80.81%
ROA:-27.39%
PB:0.71
PE(LYR):-0.27

Loading ...

Company Profile

Company Name:
Generation Bio Co.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
115
Office Location:
301 Binney Street,Cambridge,Massachusetts,United States
Zip Code:
02142
Fax:
- -
Introduction:
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Geoff McDonough
Chairman of the Board
Anthony Quinn
Director
Catherine Stehman Breen
Director
Charles Rowland
Director
Dannielle Appelhans
Director
Donald Nicholson
Director
Gustav Christensen
Director
Jason Rhodes
Director
Jeffrey Jonas
Director
Ron Cooper
Director

Shareholders

Name
Position
Yalonda Howze
Interim Chief Executive Officer,President,Chief Legal Officer and Corporate Secretary
Antionette Paone
Chief Operating Officer
Kevin Conway
Chief Financial Officer and Treasurer
Phillip Samayoa
Chief Scientific Officer